Faeth Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
28
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$200M
- Investors
-
1
Faeth General Information
Description
Operator of a data-driven, evidence-based healthcare company intended to use a deep mechanistic understanding of cancer metabolism to help in the treatment of cancer. The company is focused on matching specific diets with tumor genotypes and treatment regimens that would limit the supply of energy and building blocks that tumors require to grow, helping patients in their cancer treatments.
Contact Information
Corporate Office
- 701 Tillery Street
- Suite 12, Number 1010
- Austin, TX 78702
- United States
Corporate Office
- 701 Tillery Street
- Suite 12, Number 1010
- Austin, TX 78702
- United States
Faeth Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 17-Feb-2026 | $200M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A1) | 20-Oct-2025 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series A) | 18-Mar-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Debt - PPP | 30-Apr-2020 | $101K | Completed | Clinical Trials - Phase 1 | ||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Clinical Trials - Phase 1 |
Faeth Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Seed-6 | ||||||||
| Seed-5 | 1,060,606 | $0.000100 | 8% | $1.65 | $1.65 | 1x | $1.65 | 1.66% |
| Seed-4 | 1,454,616 | $0.000100 | 8% | $1.03 | $1.03 | 1x | $1.03 | 2.28% |
Faeth Comparisons
Industry
Financing
Details
Faeth Competitors (73)
One of Faeth’s 73 competitors is Vivace Therapeutics, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vivace Therapeutics | Venture Capital-Backed | San Mateo, CA | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Altimmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
Faeth Patents
Faeth Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026207461-A1 | Cancer therapies targeting vista | Pending | 27-Mar-2025 | ||
| WO-2025216894-A1 | Bispecific anti-vista and anti-cd28 binding proteins and uses thereof | Pending | 09-Apr-2024 | ||
| WO-2025208086-A1 | Dietary regimens and methods for treatment of colorectal cancer | Pending | 29-Mar-2024 | ||
| WO-2025207968-A1 | Hpd inhibitor compositions and methods of use | Pending | 27-Mar-2024 | ||
| AU-2024315861-A1 | Cancer therapies targeting vista as monotherapy or in combination with anti-pd1 antibody to treat cancer | Pending | 02-Aug-2023 | C07K16/2827 |
Faeth Signals
Faeth Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Able Partners | Venture Capital | Minority | ||
| AgFunder | Venture Capital | Minority | ||
| Atacama Ventures | Venture Capital | Minority | ||
| Avicella Capital | Venture Capital | Minority | ||
| B Capital Group | Venture Capital | Minority |
Faeth FAQs
-
When was Faeth founded?
Faeth was founded in 2019.
-
Where is Faeth headquartered?
Faeth is headquartered in Austin, TX.
-
What is the size of Faeth?
Faeth has 28 total employees.
-
What industry is Faeth in?
Faeth’s primary industry is Drug Discovery.
-
Is Faeth a private or public company?
Faeth is a Private company.
-
What is the current valuation of Faeth?
The current valuation of Faeth is .
-
What is Faeth’s current revenue?
The current revenue for Faeth is .
-
How much funding has Faeth raised over time?
Faeth has raised $92M.
-
Who are Faeth’s investors?
Able Partners, AgFunder, Atacama Ventures, Avicella Capital, and B Capital Group are 5 of 14 investors who have invested in Faeth.
-
Who are Faeth’s competitors?
Vivace Therapeutics, etherna, Altimmune, Oxford Biotherapeutics, and Inovio Pharmaceuticals are some of the 73 competitors of Faeth.
-
When was Faeth acquired?
Faeth was acquired on 17-Feb-2026.
-
Who acquired Faeth?
Faeth was acquired by Faeth Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process